Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127903922 | 12790392 | 2 | F | 20151117 | 20160924 | 20160928 | 20160929 | EXP | IN-ROCHE-1835351 | ROCHE | 57.28 | YR | M | Y | 0.00000 | 20160929 | MD | IN | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127903922 | 12790392 | 1 | PS | Ranibizumab | RANIBIZUMAB | 1 | Intraocular | 0.05 ML (10 MG/ML), UNK | U | 125156 | .05 | ML | SOLUTION FOR INJECTION | ||||||
| 127903922 | 12790392 | 2 | SS | Ranibizumab | RANIBIZUMAB | 1 | Intraocular | 0.05 ML (10 MG/ML), UNK | U | 125156 | .05 | ML | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127903922 | 12790392 | 1 | Diabetic retinal oedema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127903922 | 12790392 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127903922 | 12790392 | Cataract | |
| 127903922 | 12790392 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127903922 | 12790392 | 1 | 20150807 | 20150807 | 0 | |
| 127903922 | 12790392 | 2 | 20160211 | 0 |